|
PAFAH2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.51940698806175E-14 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.66420210945262E-11 |
| Normal-vs-Stage2 |
8.016400E-04 |
| Normal-vs-Stage3 |
5.23814325248395E-12 |
| Normal-vs-Stage4 |
4.84410289658399E-11 |
| Stage1-vs-Stage2 |
8.308600E-01 |
| Stage1-vs-Stage3 |
3.480100E-03 |
| Stage1-vs-Stage4 |
5.223300E-03 |
| Stage2-vs-Stage3 |
1.257810E-01 |
| Stage2-vs-Stage4 |
7.118200E-02 |
| Stage3-vs-Stage4 |
6.411200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.73228098532263E-12 |
| Normal-vs-AfricanAmerican |
5.32970334532479E-11 |
| Normal-vs-Asian |
6.58259999952726E-07 |
| Caucasian-vs-AfricanAmerican |
4.466200E-01 |
| Caucasian-vs-Asian |
2.898000E-01 |
| AfricanAmerican-vs-Asian |
4.391200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.24895707296491E-14 |
| Normal-vs-Female |
4.54629667245854E-11 |
| Male-vs-Female |
5.428400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.24169996507106E-09 |
| Normal-vs-Extreme_Weight |
1.63191682389652E-12 |
| Normal-vs-Obese |
1.12920006678507E-10 |
| Normal-vs-Extreme_Obese |
4.474600E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.088000E-01 |
| Normal_Weight-vs-Obese |
5.845800E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.707580E-01 |
| Extreme_Weight-vs-Obese |
8.953000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.098200E-01 |
| Obese-vs-Extreme_Obese |
2.267600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.9061999735377E-10 |
| Normal-vs-Age(41-60Yrs) |
2.90101276334553E-13 |
| Normal-vs-Age(61-80Yrs) |
3.89255294663826E-12 |
| Normal-vs-Age(81-100Yrs) |
4.89089990729497E-10 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.461200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.935160E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.418200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.042600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.320000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.661600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.55262477821816E-12 |
| Normal-VS-Type2 PRCC |
9.94380000562956E-09 |
| Normal-VS-KIRP CIMP |
6.25749996263636E-09 |
| Normal-VS-Unclassified PRCC |
4.7457999996503E-07 |
| Type1 PRCC-VS-Type2 PRCC |
5.265200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
7.338500E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
7.383000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.421200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
8.360400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.787400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.9336977291905E-11 |
| Normal-vs-N1 |
2.66453525910038E-15 |
| Normal-vs-N2 |
6.0591999972992E-08 |
| N0-vs-N1 |
2.337700E-02 |
| N0-vs-N2 |
2.276600E-01 |
| N1-vs-N2 |
8.151600E-01 |
|
|
